3rd Congress of the APSR

It gives me great pleasure to invite you, on behalf of the Organising Committee, to the Third Congress of the Asian-Pacific Society of Respirology (APSR) to be held in Singapore from 7th to 10th October, 1993.

The theme of the Congress is "Asia-Pacific Pulmonary Medicine - Current Challenges and Future Trends". The Scientific Committee has put together a programme that is highly relevant to the participants of the Asia-Pacific region and which should appeal to the clinician and scientist alike. Included in the scientific programme are "state-of-the-art" plenary lectures on topics such as lung transplantation, smoking and lung health and acute respiratory distress syndrome as well as several major symposia featuring practical issues in various clinical areas such as pulmonary infections, asthma and lung cancer. There will also be "specific" symposia covering areas of more specialised interest to subspecialty groups, such as critical care of the lung; and endobronchial laser and stenting and an optional pre-congress workshop on "Clinical Applications of Lasers in Respiratory Medicine". Most importantly, investigators of all ages will have ample opportunities to present and discuss their work at fully-chaired oral and poster discussion sessions.

Last but not least, we hope to present a varied and exciting social programme for all participants and accompanying persons. For those who prefer to explore the island of Singapore on their own, it is safe and easy to do so.

We look forward to seeing you in October 1993.

Wan-Cheng TAN
President of Congress

All scientific registrants, including those presenting a free paper or poster, must register as full members and pay the relevant registration fees. Registration will not be confirmed until the respective registration fee has been received by the Congress Secretariat.

To register, complete and mail Form A together with your payment to the Congress Secretariat. The registration fee must be paid in Singapore Dollars by bank draft payable to Singapore Thoracic Society A/C 2 or by credit card (Amex, MasterCard and Visa card only). Upon receipt of your registration form and the appropriate fees, an official receipt and registration card will be issued to you. Please produce the registration card at the Registration Desk to obtain your registration badge and congress satchel.

The registration fee for Scientific participants includes:

Accompanying person registration fee includes:

Registration Cancellation Policy

75% of registration fee is repayable until 31st July 1993. There will be no refund for cancellation requests received after this date. Refunds will only be made after the Congress.

Singapore Airlines Limited has been appointed official carrier for the Congress. For special fares, please present your confirmation of registration to the Singapore Airlines office near you.

The Organising Committee has secured accommodation at the Congress venue and nearby support hotels at specially reduced rates. Applications for hotel accommodation must be made on Form C. A one-night non-refundable room deposit is required to confirm hotel reservations.

A trade exhibition will be organised in conjunction with the Congress and the latest pharmaceuticals, instrumentation and equipment for clinical management and research, among others, will be featured. Companies interested in participating in the Trade Exhibition may request the Exhibitors' Information and Order Manual from the Congress Secretariat.

Pico Art International Pte Ltd and Trans-Link Exhibition Forwarding Pte Ltd have been appointed as Official Exhibition Contractor and Official Exhibition Forwarder respectively.

Tradewinds Tours and Travel is the travel agent appointed to organise tours for registered accompanying persons. Details of the Accompanying Persons' programme can be found in Page 9 of this announcement. A leaflet containing a number of interesting pre-and post-Congress optional tours in Singapore and the neighbouring countries at special prices is enclosed.

Papers from the plenary, symposia and controversies sessions will be published in the Proceedings of the Congress.

Delegates are invited to submit abstracts for oral/poster presentation on the official Abstract Reproduction Form together with Form B not later than 30th June 1993. Abstracts will not be processed until the registration Form A and registration fee have been received and acknowledged.

Yellow fever vaccination is required for visitors arriving from endemic areas. No other health documents are required.

National passport holders of most countries are permitted to stay in Singapore for up to 14 days without visas. However, visas may be required for visitors from some countries and participants are requested to clarify this before travelling.

The Organising Committee shall not be held liable for personal accidents, illness or losses or damage to private property of registered delegates of the Congress. Delegates should make their own arrangements with respect to personal insurance.

Whilst every attempt will be made to ensure that all aspects of the Congress mentioned in this announcement will take place as scheduled, the Organising Committee reserves the prerogative to make last minute changes should the need arise.

Asthma (S1)

• The role of molecular biology in clinical asthma (P. Barnes, UK)
• Airway inflammation in clinical asthma: Clinicopathophysiological correlation (J. Hogg, Canada)
• Guidelines in the management of asthma (W. C. Tan, Singapore)

Paediatric Lung Disease (S2)

• Childhood asthma: triggers, prevention and early intervention (L. Landau, Australia)
• Pulmonary function testing in infants and children (P. Sly, Australia)
• Management of bronchopulmonary dysplasia (O. M. Chay, Singapore)
• Inhaled steroid therapy in children (S. Pederson, Denmark)

Occupational Lung Disease (S3)

• Occupational asthma: An overview (M. Chan-Yeung, Canada)
• Occupational exposure and chronic obstructive lung disease (M. Chan-Yeung, Canada)
• Organic Dust lung disease (C. G. Uragoda, Sri Lanka)
• Setting up an occupational lung clinic - The Singapore Experience (Y. T. Wang, Singapore)

Pulmonary Infections (S4)

• Melioidosis (M. Sookpranee, 77miland)
• Pulmonary infections in the HIV positive patients - Singapore Experience (D .Allen, Singapore)
• Tuberculosis and non-tuberculosis mycobacterial disease: New treatment (S. K. Teo, Singapore)
• Bronchiectasis - Hong Kong Experience (W. K. Lam, Hong Kong)

Critical Care (S5)

• New methods of ventilatory support (J. Milic-Emili, Canada)
• Sepsis Syndrome and its treatment (A. C. Bone, USA)
• Understanding practical respiratory monitoring in the ICU (J. Milic-Emili, Canada)
• Pulmonary infection in the ventilated patient (W. C. Tan, Singapore)

Lung Cancer (S6)

• Molecular basis for lung cancer (J. Hogg, Canada)
• Cell type and staging in cancer management: Current concepts (A. Glanville, Australia)
• Neoadjuvant therapy (J. Wong, Singapore)
• Lasers, stents and brachytherapy (J. Dumon, France)

COPD (S7)

• New insight into epidemiology of COPD in Australasia (A. J. Woolcock, Australia)
• Diagnostic difficulties in COPD: Role of early intervention (P. Calverley, UK)
• Advances in the treatment of COPD (A. C. Bone, USA)
• Pathophysiology of chronic respiratory insufficiency (J. Milic-Emili, Canada)

Breathing Disorders in Sleep (S8)

• Pathophysiologic consequences of sleep apnoea (C. E. Sullivan, Australia)
• Assessment, treatment and outcome of sleep apnoea (N. Berend, Australia)
• Epidemiology and features of sleep apnoea in the Asia Pacific region (W. C. Tan, Singapore)

Chronic Airway Diseases (S9)

• Diffuse Panbronchiolitis - is it unique to Orientals? (S. Kira, Japan)
• From BOOP/COP to Bronchiolis Obliterans (R. M. du Bois, UK)
• Genetic basis for emphysema in the Asia Pacific region (Y. Fukuchi, Japan)

Interstitial Lung Disease (S10)

• The role of imaging in diagnosis of ILD (W. Y. Cheong, Singapore)
• The molecular basis of pathogenesis of ILD (R. M. du Bois, UK)
• Current management of Diffuse ILD (R. M. du Bois, UK)

Inhalation Therapy (S11)

• Pulmonary pathology in response to inhaled particles (J. Hogg, Canada)
• The Clinical aspects of inhaled particles (N. S. Zhong, China)
• The future of inhalational devices (G. Crompton, UK)

AUSTRALIA: N. Berend, A. Glanville, L. Landau, P. Sly, C. E. Sullivan, A. J. Woolcock

CANADA: M. Chan-Yeung, J. Hogg, J. Milic-Emili

CHINA: N. S. Zhong

DENMARK: S. Pederson

FRANCE: J. Dumon

HONG KONG: W. K. Lam, J. Mackay

JAPAN: Y. Fukuchi, M. Fukuoka, S. Kira

SINGAPORE: D. Allen, O. M. Chay, T. H. Cheong, W. Y. Cheong, K. P. Hui, F. Lee, W. C. Tan, S. K. Teo, Y. T. Wang, I. Wong

SRI LANKA: C. G. Uragoda

THAILAND: M. Sookpranee

UK: P. Barnes, P. Calverley, G. Crompton, R. M. du Bois

USA: A. C. Bone, A. Mehta

• TITLE OF PAPER IN CAPITAL LETTERS
• Name of authors in upper and lower cases, Family Name in capital and underline Family Name of presenter. Department/Hospital/Institution of First author only.
• The text should begin with a statement, in one sentence, of the main purpose of the study. A statement of methods should follow.
• A summary of the results should be presented clearly and briefly to support the conclusion.
• Conclusions reached should be precisely stated. Do not include graphs, tables and references in the abstract.